177843-80-0 Usage
Uses
Used in Polymer Industry:
[1,1-Biphenyl]-2,3,5-triamine is used as a monomer for the production of phenolic resins and polyimides. Its role in this application is to serve as a building block for creating polymers with specific properties, such as heat resistance and chemical stability.
Used in Organic Synthesis:
In the field of organic synthesis, [1,1-Biphenyl]-2,3,5-triamine is used as a reagent. It is valuable for its ability to participate in various chemical reactions, contributing to the formation of a wide range of compounds.
Used in Dyes and Pigments Industry:
This chemical compound is also utilized as a precursor for dyes and pigments. Its role in this application is to provide the necessary structure or functional groups that can be further modified or processed to produce the desired colorants.
Used in Analytical Chemistry:
[1,1-Biphenyl]-2,3,5-triamine finds application in analytical chemistry for the determination of various compounds. It serves as a tool to help identify, quantify, or analyze target substances in a given sample, which can be crucial in research and quality control processes.
Check Digit Verification of cas no
The CAS Registry Mumber 177843-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,8,4 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 177843-80:
(8*1)+(7*7)+(6*7)+(5*8)+(4*4)+(3*3)+(2*8)+(1*0)=180
180 % 10 = 0
So 177843-80-0 is a valid CAS Registry Number.
177843-80-0Relevant articles and documents
SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
, (2008/06/13)
The present invention relates to compounds having the general structure: (I) and pharmaceutically acceptable salts and hydrates thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple m
Substituted heterocyclic compounds and methods of use
-
Page/Page column 14-15, (2008/06/13)
The present invention relates to compounds having the general structure: and pharmaceutically acceptable salts and hydrates thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myelo